The Insomnia Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Insomnia Treatment Drugs market size is estimated to be worth US$ 3006.2 million in 2021 and is forecast to a readjusted size of USD 3764 million by 2028 with a CAGR of 3.3% during review period. Hospital accounting for % of the Insomnia Treatment Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Prescription Sleep Aids segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Insomnia Treatment Drugs include F.Hoffman La-Roche AG, Merck & Co. Inc., Mylan N.V., Pfizer, Inc., and Pernix Therapeutics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Insomnia Treatment Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prescription Sleep Aids
Over the Counter (OTC) Sleep Aids
Market segment by Application, can be divided into
Hospital
Pharmacy
Others
Market segment by players, this report covers
F.Hoffman La-Roche AG
Merck & Co. Inc.
Mylan N.V.
Pfizer, Inc.
Pernix Therapeutics
Sanofi S.A.
Takeda Pharmaceutical Company Ltd.
Sumitomo Dainippon Pharma Co., Ltd
Teva Pharmaceutical Industries Ltd.
Vanda Pharmaceuticals, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Insomnia Treatment Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Insomnia Treatment Drugs, with revenue, gross margin and global market share of Insomnia Treatment Drugs from 2019 to 2022.
Chapter 3, the Insomnia Treatment Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Insomnia Treatment Drugs market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Insomnia Treatment Drugs research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Insomnia Treatment Drugs
1.2 Classification of Insomnia Treatment Drugs by Type
1.2.1 Overview: Global Insomnia Treatment Drugs Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Insomnia Treatment Drugs Revenue Market Share by Type in 2021
1.2.3 Prescription Sleep Aids
1.2.4 Over the Counter (OTC) Sleep Aids
1.3 Global Insomnia Treatment Drugs Market by Application
1.3.1 Overview: Global Insomnia Treatment Drugs Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Global Insomnia Treatment Drugs Market Size & Forecast
1.5 Global Insomnia Treatment Drugs Market Size and Forecast by Region
1.5.1 Global Insomnia Treatment Drugs Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Insomnia Treatment Drugs Market Size by Region, (2017-2022)
1.5.3 North America Insomnia Treatment Drugs Market Size and Prospect (2017-2028)
1.5.4 Europe Insomnia Treatment Drugs Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Insomnia Treatment Drugs Market Size and Prospect (2017-2028)
1.5.6 South America Insomnia Treatment Drugs Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Insomnia Treatment Drugs Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Insomnia Treatment Drugs Market Drivers
1.6.2 Insomnia Treatment Drugs Market Restraints
1.6.3 Insomnia Treatment Drugs Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 F.Hoffman La-Roche AG
2.1.1 F.Hoffman La-Roche AG Details
2.1.2 F.Hoffman La-Roche AG Major Business
2.1.3 F.Hoffman La-Roche AG Insomnia Treatment Drugs Product and Solutions
2.1.4 F.Hoffman La-Roche AG Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 F.Hoffman La-Roche AG Recent Developments and Future Plans
2.2 Merck & Co. Inc.
2.2.1 Merck & Co. Inc. Details
2.2.2 Merck & Co. Inc. Major Business
2.2.3 Merck & Co. Inc. Insomnia Treatment Drugs Product and Solutions
2.2.4 Merck & Co. Inc. Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Merck & Co. Inc. Recent Developments and Future Plans
2.3 Mylan N.V.
2.3.1 Mylan N.V. Details
2.3.2 Mylan N.V. Major Business
2.3.3 Mylan N.V. Insomnia Treatment Drugs Product and Solutions
2.3.4 Mylan N.V. Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Mylan N.V. Recent Developments and Future Plans
2.4 Pfizer, Inc.
2.4.1 Pfizer, Inc. Details
2.4.2 Pfizer, Inc. Major Business
2.4.3 Pfizer, Inc. Insomnia Treatment Drugs Product and Solutions
2.4.4 Pfizer, Inc. Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Pfizer, Inc. Recent Developments and Future Plans
2.5 Pernix Therapeutics
2.5.1 Pernix Therapeutics Details
2.5.2 Pernix Therapeutics Major Business
2.5.3 Pernix Therapeutics Insomnia Treatment Drugs Product and Solutions
2.5.4 Pernix Therapeutics Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Pernix Therapeutics Recent Developments and Future Plans
2.6 Sanofi S.A.
2.6.1 Sanofi S.A. Details
2.6.2 Sanofi S.A. Major Business
2.6.3 Sanofi S.A. Insomnia Treatment Drugs Product and Solutions
2.6.4 Sanofi S.A. Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Sanofi S.A. Recent Developments and Future Plans
2.7 Takeda Pharmaceutical Company Ltd.
2.7.1 Takeda Pharmaceutical Company Ltd. Details
2.7.2 Takeda Pharmaceutical Company Ltd. Major Business
2.7.3 Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Product and Solutions
2.7.4 Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Takeda Pharmaceutical Company Ltd. Recent Developments and Future Plans
2.8 Sumitomo Dainippon Pharma Co., Ltd
2.8.1 Sumitomo Dainippon Pharma Co., Ltd Details
2.8.2 Sumitomo Dainippon Pharma Co., Ltd Major Business
2.8.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Product and Solutions
2.8.4 Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Sumitomo Dainippon Pharma Co., Ltd Recent Developments and Future Plans
2.9 Teva Pharmaceutical Industries Ltd.
2.9.1 Teva Pharmaceutical Industries Ltd. Details
2.9.2 Teva Pharmaceutical Industries Ltd. Major Business
2.9.3 Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Product and Solutions
2.9.4 Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.10 Vanda Pharmaceuticals, Inc.
2.10.1 Vanda Pharmaceuticals, Inc. Details
2.10.2 Vanda Pharmaceuticals, Inc. Major Business
2.10.3 Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Product and Solutions
2.10.4 Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Vanda Pharmaceuticals, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Insomnia Treatment Drugs Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Insomnia Treatment Drugs Players Market Share in 2021
3.2.2 Top 10 Insomnia Treatment Drugs Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Insomnia Treatment Drugs Players Head Office, Products and Services Provided
3.4 Insomnia Treatment Drugs Mergers & Acquisitions
3.5 Insomnia Treatment Drugs New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Insomnia Treatment Drugs Revenue and Market Share by Type (2017-2022)
4.2 Global Insomnia Treatment Drugs Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Insomnia Treatment Drugs Revenue Market Share by Application (2017-2022)
5.2 Global Insomnia Treatment Drugs Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Insomnia Treatment Drugs Revenue by Type (2017-2028)
6.2 North America Insomnia Treatment Drugs Revenue by Application (2017-2028)
6.3 North America Insomnia Treatment Drugs Market Size by Country
6.3.1 North America Insomnia Treatment Drugs Revenue by Country (2017-2028)
6.3.2 United States Insomnia Treatment Drugs Market Size and Forecast (2017-2028)
6.3.3 Canada Insomnia Treatment Drugs Market Size and Forecast (2017-2028)
6.3.4 Mexico Insomnia Treatment Drugs Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Insomnia Treatment Drugs Revenue by Type (2017-2028)
7.2 Europe Insomnia Treatment Drugs Revenue by Application (2017-2028)
7.3 Europe Insomnia Treatment Drugs Market Size by Country
7.3.1 Europe Insomnia Treatment Drugs Revenue by Country (2017-2028)
7.3.2 Germany Insomnia Treatment Drugs Market Size and Forecast (2017-2028)
7.3.3 France Insomnia Treatment Drugs Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Insomnia Treatment Drugs Market Size and Forecast (2017-2028)
7.3.5 Russia Insomnia Treatment Drugs Market Size and Forecast (2017-2028)
7.3.6 Italy Insomnia Treatment Drugs Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Insomnia Treatment Drugs Revenue by Type (2017-2028)
8.2 Asia-Pacific Insomnia Treatment Drugs Revenue by Application (2017-2028)
8.3 Asia-Pacific Insomnia Treatment Drugs Market Size by Region
8.3.1 Asia-Pacific Insomnia Treatment Drugs Revenue by Region (2017-2028)
8.3.2 China Insomnia Treatment Drugs Market Size and Forecast (2017-2028)
8.3.3 Japan Insomnia Treatment Drugs Market Size and Forecast (2017-2028)
8.3.4 South Korea Insomnia Treatment Drugs Market Size and Forecast (2017-2028)
8.3.5 India Insomnia Treatment Drugs Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Insomnia Treatment Drugs Market Size and Forecast (2017-2028)
8.3.7 Australia Insomnia Treatment Drugs Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Insomnia Treatment Drugs Revenue by Type (2017-2028)
9.2 South America Insomnia Treatment Drugs Revenue by Application (2017-2028)
9.3 South America Insomnia Treatment Drugs Market Size by Country
9.3.1 South America Insomnia Treatment Drugs Revenue by Country (2017-2028)
9.3.2 Brazil Insomnia Treatment Drugs Market Size and Forecast (2017-2028)
9.3.3 Argentina Insomnia Treatment Drugs Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Insomnia Treatment Drugs Revenue by Type (2017-2028)
10.2 Middle East & Africa Insomnia Treatment Drugs Revenue by Application (2017-2028)
10.3 Middle East & Africa Insomnia Treatment Drugs Market Size by Country
10.3.1 Middle East & Africa Insomnia Treatment Drugs Revenue by Country (2017-2028)
10.3.2 Turkey Insomnia Treatment Drugs Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Insomnia Treatment Drugs Market Size and Forecast (2017-2028)
10.3.4 UAE Insomnia Treatment Drugs Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Insomnia Treatment Drugs Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Insomnia Treatment Drugs Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Insomnia Treatment Drugs Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Insomnia Treatment Drugs Revenue (USD Million) by Region (2017-2022)
Table 5. Global Insomnia Treatment Drugs Revenue Market Share by Region (2023-2028)
Table 6. F.Hoffman La-Roche AG Corporate Information, Head Office, and Major Competitors
Table 7. F.Hoffman La-Roche AG Major Business
Table 8. F.Hoffman La-Roche AG Insomnia Treatment Drugs Product and Solutions
Table 9. F.Hoffman La-Roche AG Insomnia Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Merck & Co. Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Merck & Co. Inc. Major Business
Table 12. Merck & Co. Inc. Insomnia Treatment Drugs Product and Solutions
Table 13. Merck & Co. Inc. Insomnia Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Mylan N.V. Corporate Information, Head Office, and Major Competitors
Table 15. Mylan N.V. Major Business
Table 16. Mylan N.V. Insomnia Treatment Drugs Product and Solutions
Table 17. Mylan N.V. Insomnia Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Pfizer, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Pfizer, Inc. Major Business
Table 20. Pfizer, Inc. Insomnia Treatment Drugs Product and Solutions
Table 21. Pfizer, Inc. Insomnia Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Pernix Therapeutics Corporate Information, Head Office, and Major Competitors
Table 23. Pernix Therapeutics Major Business
Table 24. Pernix Therapeutics Insomnia Treatment Drugs Product and Solutions
Table 25. Pernix Therapeutics Insomnia Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Sanofi S.A. Corporate Information, Head Office, and Major Competitors
Table 27. Sanofi S.A. Major Business
Table 28. Sanofi S.A. Insomnia Treatment Drugs Product and Solutions
Table 29. Sanofi S.A. Insomnia Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Takeda Pharmaceutical Company Ltd. Corporate Information, Head Office, and Major Competitors
Table 31. Takeda Pharmaceutical Company Ltd. Major Business
Table 32. Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Product and Solutions
Table 33. Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Sumitomo Dainippon Pharma Co., Ltd Corporate Information, Head Office, and Major Competitors
Table 35. Sumitomo Dainippon Pharma Co., Ltd Major Business
Table 36. Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Product and Solutions
Table 37. Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Teva Pharmaceutical Industries Ltd. Corporate Information, Head Office, and Major Competitors
Table 39. Teva Pharmaceutical Industries Ltd. Major Business
Table 40. Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Product and Solutions
Table 41. Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Vanda Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
Table 43. Vanda Pharmaceuticals, Inc. Major Business
Table 44. Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Product and Solutions
Table 45. Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Insomnia Treatment Drugs Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Insomnia Treatment Drugs Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Insomnia Treatment Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Insomnia Treatment Drugs Players Head Office, Products and Services Provided
Table 50. Insomnia Treatment Drugs Mergers & Acquisitions in the Past Five Years
Table 51. Insomnia Treatment Drugs New Entrants and Expansion Plans
Table 52. Global Insomnia Treatment Drugs Revenue (USD Million) by Type (2017-2022)
Table 53. Global Insomnia Treatment Drugs Revenue Share by Type (2017-2022)
Table 54. Global Insomnia Treatment Drugs Revenue Forecast by Type (2023-2028)
Table 55. Global Insomnia Treatment Drugs Revenue by Application (2017-2022)
Table 56. Global Insomnia Treatment Drugs Revenue Forecast by Application (2023-2028)
Table 57. North America Insomnia Treatment Drugs Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Insomnia Treatment Drugs Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Insomnia Treatment Drugs Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Insomnia Treatment Drugs Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Insomnia Treatment Drugs Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Insomnia Treatment Drugs Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Insomnia Treatment Drugs Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Insomnia Treatment Drugs Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Insomnia Treatment Drugs Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Insomnia Treatment Drugs Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Insomnia Treatment Drugs Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Insomnia Treatment Drugs Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Insomnia Treatment Drugs Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Insomnia Treatment Drugs Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Insomnia Treatment Drugs Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Insomnia Treatment Drugs Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Insomnia Treatment Drugs Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Insomnia Treatment Drugs Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Insomnia Treatment Drugs Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Insomnia Treatment Drugs Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Insomnia Treatment Drugs Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Insomnia Treatment Drugs Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Insomnia Treatment Drugs Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Insomnia Treatment Drugs Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Insomnia Treatment Drugs Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Insomnia Treatment Drugs Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Insomnia Treatment Drugs Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Insomnia Treatment Drugs Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Insomnia Treatment Drugs Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Insomnia Treatment Drugs Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Insomnia Treatment Drugs Picture
Figure 2. Global Insomnia Treatment Drugs Revenue Market Share by Type in 2021
Figure 3. Prescription Sleep Aids
Figure 4. Over the Counter (OTC) Sleep Aids
Figure 5. Insomnia Treatment Drugs Revenue Market Share by Application in 2021
Figure 6. Hospital Picture
Figure 7. Pharmacy Picture
Figure 8. Others Picture
Figure 9. Global Insomnia Treatment Drugs Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Insomnia Treatment Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Insomnia Treatment Drugs Revenue Market Share by Region (2017-2028)
Figure 12. Global Insomnia Treatment Drugs Revenue Market Share by Region in 2021
Figure 13. North America Insomnia Treatment Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Insomnia Treatment Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Insomnia Treatment Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Insomnia Treatment Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Insomnia Treatment Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Insomnia Treatment Drugs Market Drivers
Figure 19. Insomnia Treatment Drugs Market Restraints
Figure 20. Insomnia Treatment Drugs Market Trends
Figure 21. F.Hoffman La-Roche AG Recent Developments and Future Plans
Figure 22. Merck & Co. Inc. Recent Developments and Future Plans
Figure 23. Mylan N.V. Recent Developments and Future Plans
Figure 24. Pfizer, Inc. Recent Developments and Future Plans
Figure 25. Pernix Therapeutics Recent Developments and Future Plans
Figure 26. Sanofi S.A. Recent Developments and Future Plans
Figure 27. Takeda Pharmaceutical Company Ltd. Recent Developments and Future Plans
Figure 28. Sumitomo Dainippon Pharma Co., Ltd Recent Developments and Future Plans
Figure 29. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
Figure 30. Vanda Pharmaceuticals, Inc. Recent Developments and Future Plans
Figure 31. Global Insomnia Treatment Drugs Revenue Share by Players in 2021
Figure 32. Insomnia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 33. Global Top 3 Players Insomnia Treatment Drugs Revenue Market Share in 2021
Figure 34. Global Top 10 Players Insomnia Treatment Drugs Revenue Market Share in 2021
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 36. Global Insomnia Treatment Drugs Revenue Share by Type in 2021
Figure 37. Global Insomnia Treatment Drugs Market Share Forecast by Type (2023-2028)
Figure 38. Global Insomnia Treatment Drugs Revenue Share by Application in 2021
Figure 39. Global Insomnia Treatment Drugs Market Share Forecast by Application (2023-2028)
Figure 40. North America Insomnia Treatment Drugs Sales Market Share by Type (2017-2028)
Figure 41. North America Insomnia Treatment Drugs Sales Market Share by Application (2017-2028)
Figure 42. North America Insomnia Treatment Drugs Revenue Market Share by Country (2017-2028)
Figure 43. United States Insomnia Treatment Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Insomnia Treatment Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Insomnia Treatment Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Insomnia Treatment Drugs Sales Market Share by Type (2017-2028)
Figure 47. Europe Insomnia Treatment Drugs Sales Market Share by Application (2017-2028)
Figure 48. Europe Insomnia Treatment Drugs Revenue Market Share by Country (2017-2028)
Figure 49. Germany Insomnia Treatment Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Insomnia Treatment Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Insomnia Treatment Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Insomnia Treatment Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Insomnia Treatment Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Insomnia Treatment Drugs Sales Market Share by Type (2017-2028)
Figure 55. Asia-Pacific Insomnia Treatment Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Insomnia Treatment Drugs Revenue Market Share by Region (2017-2028)
Figure 57. China Insomnia Treatment Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Insomnia Treatment Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. South Korea Insomnia Treatment Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Insomnia Treatment Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Insomnia Treatment Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Insomnia Treatment Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Insomnia Treatment Drugs Sales Market Share by Type (2017-2028)
Figure 64. South America Insomnia Treatment Drugs Sales Market Share by Application (2017-2028)
Figure 65. South America Insomnia Treatment Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Insomnia Treatment Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Insomnia Treatment Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East and Africa Insomnia Treatment Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East and Africa Insomnia Treatment Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East and Africa Insomnia Treatment Drugs Revenue Market Share by Country (2017-2028)
Figure 71. Turkey Insomnia Treatment Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Saudi Arabia Insomnia Treatment Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. UAE Insomnia Treatment Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source